1983
Tomographic Gallium-67 Citrate Scanning Useful New Surveillance for Metastatic Melanoma
KIRKWOOD J, MYERS J, VLOCK D, NEUMANN R, ARIYAN S, GOTTSCHALK A, HOFFER P. Tomographic Gallium-67 Citrate Scanning Useful New Surveillance for Metastatic Melanoma. Annals Of Surgery 1983, 198: 102-107. PMID: 6859984, PMCID: PMC1352941, DOI: 10.1097/00000658-198307000-00020.Peer-Reviewed Original ResearchConceptsLymph nodesMetastatic melanomaTomographic scanBone sitesEvident lymph nodesIndependent clinical evaluationProspective surveillance studyPeripheral lymph nodesSoft tissue sitesLymphatic sitesMediastinal sitesGallium scanGallium imagingPulmonary sitesClinical evaluationTomographic scanningAbdominal sitesGallium uptakeBrain sitesOsseous sitesSurveillance studyDiscordant findingsTissue sitesOverall sensitivityMelanoma
1982
Tomographic gallium-67 citrate scanning: useful new surveillance for metastatic melanoma.
Kirkwood J, Myers J, Vlock D, Neumann R, Ariyan S, Gottschalk A, Hoffer P. Tomographic gallium-67 citrate scanning: useful new surveillance for metastatic melanoma. Annals Of Internal Medicine 1982, 97: 694-9. PMID: 7137734, DOI: 10.7326/0003-4819-97-5-694.Peer-Reviewed Original ResearchConceptsLymph nodesMetastatic melanomaTomographic scanBone sitesEvident lymph nodesIndependent clinical evaluationProspective surveillance studyPeripheral lymph nodesSoft tissue sitesLymphatic sitesMediastinal sitesGallium scanGallium imagingPulmonary sitesClinical evaluationTomographic scanningAbdominal sitesGallium uptakeBrain sitesOsseous sitesSurveillance studyDiscordant findingsTissue sitesOverall sensitivityMelanomaIntralymphatic and regional surgical adjuvant immunotherapy in high-risk melanoma of the extremities.
Ariyan S, Kirkwood J, Mitchell M, Nordlund J, Lerner A, Papac R. Intralymphatic and regional surgical adjuvant immunotherapy in high-risk melanoma of the extremities. Surgery 1982, 92: 459-63. PMID: 7112396.Peer-Reviewed Original ResearchConceptsBacillus Calmette-GuerinSurgical adjuvant immunotherapyMER-BCGAdjuvant immunotherapyControl groupHigh-risk malignant melanomaDisease-free survivalHigh-risk melanomaIntraoperative infiltrationImmunotherapy groupIntradermal vaccinationIntralymphatic immunotherapyRegional lymphadenectomyConsecutive patientsSurgical excisionCalmette-GuerinMalignant melanomaPatientsImmunotherapyMethanol-extractable residueLymphadenectomyRecurrenceMelanomaExtremitiesSame interval